D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
MDGL holding history
Madrigal Pharmaceuticals, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MDGL overviewAll 13F holders of MDGLFull Q2 2026 holdings
- Shares (Q2 2026)
- 724
- Value
- $388.8K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 724 | $388.8K | <0.1% | −1,099−60.3% | Reduced | Holders |
| Q1 2026 | 1,823 | $954.3K | <0.1% | −306−14.4% | Reduced | Holders |
| Q4 2025 | 2,129 | $1.24M | <0.1% | +58+2.8% | Added | Holders |
| Q3 2025 | 2,071 | $949.9K | <0.1% | +518+33.4% | Added | Holders |
| Q2 2025 | 1,553 | $470.0K | <0.1% | −620−28.5% | Reduced | Holders |
| Q1 2025 | 2,173 | $719.8K | <0.1% | +1,458+203.9% | Added | Holders |
| Q4 2024 | 715 | $220.6K | <0.1% | +715 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −715−100.0% | Sold out | Holders |
| Q2 2024 | 715 | $200.3K | <0.1% | +715 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −720−100.0% | Sold out | Holders |
| Q4 2022 | 720 | $209.0K | <0.1% | +720 | New | Holders |